NSC156529

has antineoplastic activity; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Belitškin, Denis: 1 article (01/2016)
2.	Jaks, Viljar: 1 article (01/2016)
3.	Mäemets-Allas, Kristina: 1 article (01/2016)

1.	Neoplasms (Cancer) 01/01/2016 - "We conclude that the Akt pathway inhibitor NSC156529 is potentially useful as single treatment for liver tumors with hyperactivated Akt signaling."